Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 18.19%21.62M | 23.47%26.45M | 21.75%18.29M | 63.67%21.43M | 36.70%17.89M | 49.16%15.03M | -44.43%4M | -84.34%13.09M | -76.55%13.09M | -79.06%10.07M |
| Operating income | 18.19%21.62M | 23.47%26.45M | 21.75%18.29M | 63.67%21.43M | 36.70%17.89M | 49.16%15.03M | -44.43%4M | -84.34%13.09M | -76.55%13.09M | -79.06%10.07M |
| Cost of sales | -21.61%-7.68M | -24.02%-16.39M | -18.21%-6.31M | -79.84%-13.21M | 15.00%-6.72M | 17.39%-5.34M | 71.15%-1.03M | 62.79%-7.35M | 32.78%-7.91M | 33.62%-6.46M |
| Operating expenses | -21.61%-7.68M | -24.02%-16.39M | -18.21%-6.31M | -79.84%-13.21M | 15.00%-6.72M | 17.39%-5.34M | 71.15%-1.03M | 62.79%-7.35M | 32.78%-7.91M | 33.62%-6.46M |
| Gross profit | 16.38%13.95M | 22.59%10.07M | 23.70%11.98M | 42.99%8.21M | 115.61%11.17M | 168.31%9.69M | -18.40%2.98M | -91.01%5.74M | -88.24%5.18M | -90.59%3.61M |
| Administrative expenses | -33.56%-1.39M | -32.47%-10.08M | 1.14%-1.04M | 45.57%-7.61M | 16.08%-4.25M | -28.14%-1.05M | 10.70%-1.96M | 34.67%-13.97M | 62.02%-5.07M | 85.97%-821K |
| Employee expense | -2.19%-2.33M | ---- | -24.86%-2.28M | ---- | ---- | 35.36%-1.83M | ---- | ---- | ---- | 40.70%-2.83M |
| Impairment and provision | ---- | 74.83%-14.84M | ---- | -653.00%-58.94M | ---- | ---- | ---- | -1,954.33%-7.83M | ---- | ---- |
| -Other impairment is provision | ---- | 74.83%-14.84M | ---- | -653.00%-58.94M | ---- | ---- | ---- | -1,954.33%-7.83M | ---- | ---- |
| Special items of operating profit | 0.00%4K | 210.00%372K | -77.78%4K | -51.61%120K | -70.67%44K | -84.75%18K | -34.48%38K | -42.46%248K | -57.26%150K | -53.36%118K |
| Operating profit | 18.05%10.23M | 75.14%-14.47M | 26.96%8.67M | -268.21%-58.21M | 2,556.87%6.96M | 8,224.39%6.83M | -30.24%1.05M | -137.17%-15.81M | -99.16%262K | -99.71%82K |
| Financing cost | 126.67%4K | ---- | -153.57%-15K | ---- | 164.52%20K | 250.00%28K | -166.67%-4K | -13.33%-17K | -181.82%-31K | 153.33%8K |
| Earning before tax | 18.30%10.23M | 75.14%-14.47M | 26.22%8.65M | -267.82%-58.21M | 2,922.08%6.98M | 7,515.56%6.85M | -30.78%1.05M | -137.22%-15.83M | -99.26%231K | -99.68%90K |
| Tax | -18.26%-1.54M | ---46K | -26.26%-1.3M | ---- | -2,584.62%-1.05M | -4,369.57%-1.03M | 30.84%-157K | ---- | 99.26%-39K | 99.52%-23K |
| After-tax profit from continuing operations | 18.31%8.7M | 75.06%-14.52M | 26.21%7.35M | -267.82%-58.21M | 2,990.63%5.93M | 8,595.52%5.83M | -30.77%891K | -143.57%-15.83M | -99.26%192K | -99.71%67K |
| Earning after tax | 18.31%8.7M | 75.06%-14.52M | 26.21%7.35M | -267.82%-58.21M | 2,990.63%5.93M | 8,595.52%5.83M | -30.77%891K | -143.57%-15.83M | -99.26%192K | -99.71%67K |
| Minority profit | ---- | ---- | ---- | ---197K | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 18.31%8.7M | 74.97%-14.52M | 26.21%7.35M | -266.57%-58.01M | 2,990.63%5.93M | 8,595.52%5.83M | -30.77%891K | -143.57%-15.83M | -99.26%192K | -99.71%67K |
| Basic earnings per share | 17.57%0.0087 | 74.96%-0.0146 | 23.33%0.0074 | -266.67%-0.0583 | 2,900.00%0.006 | 0.006 | -30.77%0.0009 | -143.56%-0.0159 | -99.23%0.0002 | 0 |
| Diluted earnings per share | 17.57%0.0087 | 74.96%-0.0146 | 23.33%0.0074 | -266.67%-0.0583 | 2,900.00%0.006 | 0.006 | -30.77%0.0009 | -143.56%-0.0159 | -99.23%0.0002 | 0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Auditor | -- | Hwashin Certified Public Accountants Limited | -- | Hwashin Certified Public Accountants Limited | -- | -- | -- | Hwashin Certified Public Accountants Limited | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.